Company Legal Name
Latest Valuation
Founded Year
Headquarter
BioCatch Ltd. operates a behavioral biometric intelligence platform that detects digital fraud and prevents financial crimes by analyzing user behavior patterns. Founded in 2011 and headquartered in Tel Aviv, Israel, the company leverages machine learning to identify anomalies in how users interact with digital devices, creating unique behavioral profiles for authentication and risk assessment. BioCatch serves financial institutions, payment processors, and other organizations seeking advanced fraud prevention capabilities beyond traditional security measures. The platform monitors factors like typing patterns, mouse movements, and mobile device interactions to distinguish legitimate users from fraudsters in real-time, positioning itself as a leader in behavioral biometrics cybersecurity.
Revenue & Revenue Growth Share
Revenue
Revenue Growth
Available in most regions; subject to local regulations.
Open to non-accredited investors with KYC/AML compliance. U.S. investors must meet SEC requirements.
$10 per token, enabling fractionalized access to Pre-IPO shares.
Mandatory identity (KYC) and proof of funds checks.
Variable, applied to investment amounts.
Charged on realized profits.
Tokens may be locked for 6–12 months; resale depends on secondary market liquidity.
Prices reflect past funding rounds, not guaranteed future value.
Biotech depends on regulatory approvals; fintech faces evolving digital asset rules.
Blockchain or custodian issues could delay transfers or verification.
Changing laws may affect tradability or taxation.





